Camurus AB EBIT

Camurus AB (CAMX.ST) currently reports a EBIT of $860M as of June 2026. That compares with $920M in the prior-year period — down 6.4% year over year. That is below the Healthcare sector average of $1.9T. Use the charts on this page to explore Camurus AB's EBIT history and peer comparisons.

Camurus AB's EBIT decreased from $920M to $860M — a 6.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Camurus AB's EBIT of $860M is lower than the Healthcare sector average of $1.9T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Camurus AB reported $860M in EBIT as of June 2026. That compares with $920M in the prior-year period — down 6.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $860M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $1.9T. From there, open related valuation or income-statement pages for Camurus AB, and consider following CAMX.ST for alerts when major investors trade the stock.